Safeguard Scientifics Inc.

SFES OTC SEC CIK 86115
Follow Safeguard Scientifics Weekly email: filings, results

Financials

Reported figures only · latest: fiscal 2023 USD · US GAAP
Net income −$9.8M +31.1% vs prior year
EPS, diluted −$0.61 +29.9% vs prior year
Operating cash flow −$3.3M −1.5% vs prior year
Operating income −$5.7M −19% vs prior year
Net income by fiscal year
−$15.6M
$54.6M
−$37.6M
$27M
−$14.3M
−$9.8M
FY18 FY19 FY20 FY21 FY22 FY23

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
−$100M−$50M$0$50M$100M$150MFY09FY11FY13FY15FY17FY19FY21FY23
Show the numbers
YearNet income
FY23−$9.8M
FY22−$14.3M
FY21$27M
FY20−$37.6M
FY19$54.6M
FY18−$15.6M
FY17−$88.6M
FY16−$22.3M
FY15−$59.5M
FY14−$5.1M
FY13−$35.5M
FY12−$39.4M
FY11$110.6M
FY10$26.6M
FY09$67.6M
Free cash flowOperating cash flow minus capital expenditure
−$30M−$20M−$10M$0FY09FY11FY13FY15FY17FY19FY21FY23
Show the numbers
YearFree cash flow
FY23-
FY22-
FY21-
FY20-
FY19-
FY18-
FY17−$20.8M
FY16−$19.1M
FY15−$19.6M
FY14−$20.2M
FY13−$21.3M
FY12−$16.6M
FY11−$17.8M
FY10−$16.1M
FY09−$21.3M
Returned to shareholdersDividends paid and shares bought back
  • Dividends
  • Buybacks
$0$20M$40M$60MFY09FY11FY13FY15FY17FY19FY21FY23
Show the numbers
YearDividendsBuybacks
FY23$5.8M$75K
FY22$0$2.9M
FY21-$40.7M
FY20$0$0
FY19$20.7M-
FY18$0-
FY17-$0
FY16-$5.4M
FY15-$5M
FY14-$25M
FY13-$122K
FY12-$0
FY11-$0
FY10--
FY09-$44K